6 天前 - … Irritable bowel syndrome (IBS) is a major global healthcare burden that requires
effective and well-tolerated intervention. This study aimed to investigate the effectiveness and …

7 天前 - … Citation7 This article reviews current and emerging treatment options and disease
… care provider (HCP) relationship and patient education in diagnosis and treatment. …

8 天前 - … bowel disease, irritable bowel syndrome, colon polyps, colorectal and stomach
cancer are discussed and their effects on the digestive system and potential properties in …

15 天前 - … Despite their high prevalence and limited treatment options, there is a paucity of …
In irritable bowel syndrome, the experience sampling method and wristband actigraphy …

16 天前 - … Rifaximin, a broad‐spectrum antibiotic, boasts a unique chemical composition and
pharmacokinetic profile, rendering it highly effective in treating irritable bowel syndrome (IBS)…

17 天前 - … Treatment of nonconstipated irritable bowel syndrome with the … Overlap syndrome
of functional dyspepsia and irritable bowel … Overlap of irritable bowel syndrome and functional …

37 天前 - … with treatment as usual, providing more options for the treatment of refractory IBS. …
Chinese expert consensus of irritable bowel syndrome in 2020. Chin J Dig 2020; 40(12)…

38 天前 - … aimed to explore the optimal intervention for gut microbiota and provide better
treatment options for clinical practice, as well as directions for further research in IBS treatment. …

38 天前 - … The post-infection development of Irritable Bowel Syndrome (IBS), one of the most
… of a possible association COVID-19Post-infectious irritable bowel syndrome (PI-IBS), with …

42 天前 - … for irritable bowel syndrome (IBS), the proposed biomarkers to identify individual
mechanisms and phenotypes in these conditions, and cost considerations for treatments …